By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Xenetic Biosciences  

Greener House
66-68 Haymarket
  London  SW1Y 4RF  United Kingdom
Phone: 44-0-20-3021-1500 Fax: 44-0-20-3021-1511


Company News
Xenetic Biosciences Enters Into Asset Purchase Agreement With Financing Component For The Rights To Develop, Market And License Oncologic Drug Candidate Virexxa™ 11/16/2015 11:15:26 AM
Xenetic Biosciences's Major Strategic Shareholders Enter Into Long Term Lock-Up Agreements 10/7/2015 11:16:11 AM
Xenetic Biosciences Launches Digital Corporate Communication Channels 9/2/2015 7:52:13 AM
Xenetic Biosciences Announces Board Change 4/22/2015 8:18:57 AM
Xenetic Biosciences To Hold Business Update Conference Call January 20th 1/19/2015 11:12:25 AM
Xenetic Biosciences Completes Enrollment Of Second Cohort In Phase 2a Study With Erepoxen® For Anemia; Hemoglobin Levels Rise Into Therapeutic Range Over Time 12/19/2014 11:18:51 AM
Xenetic Biosciences CEO Delivers “2014 – The Year In Review” Update To Investors And Stakeholders 12/18/2014 9:28:47 AM
Xenetic Biosciences Announces OncoHist™ Preclinical Data To Be Featured In A Poster Presentation At The American Society of Hematology Annual Meeting 12/4/2014 9:58:06 AM
Xenetic Biosciences Partner Completes Dosing Of Second Cohort In Phase 2a Study Of Erepoxen® In Patients With Chronic Kidney Disease On Dialysis 12/2/2014 11:35:23 AM
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide 11/25/2014 9:04:16 AM